Literature DB >> 21237198

The neuropsychiatry of neuroacanthocytosis syndromes.

Mark Walterfang1, Andrew Evans, Jeffrey Chee Leong Looi, Hans H Jung, Adrian Danek, Ruth H Walker, Dennis Velakoulis.   

Abstract

The neuroacanthocytoses are a group of disorders characterised by peripheral blood acanthocytes, central nervous system as well as neuromuscular symptoms. These disorders uniformly result in pathology in the basal ganglia, which account for the characteristic motor symptoms such as chorea or dystonia, but may also account for the apparent elevated rates of major mental disorders in these syndromes. Elevated rates of dysexecutive syndromes, obsessive-compulsive disorder, depression and schizophrenia-like psychosis appear to occur in chorea-acanthocytosis, McLeod's syndrome, pantothenate kinase-associated neurodegeneration, and Huntington's disease-like 2. Disruptions to key frontostriatal loops secondary to pathology in the striatum and pallidum appear to predispose individuals to major neuropsychiatric syndromes; however, treatment can be instituted for a number of these manifestations, which lessens the overall burden of disease in neuroacanthocytosis patients and their families.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21237198     DOI: 10.1016/j.neubiorev.2011.01.001

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  12 in total

Review 1.  XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease.

Authors:  Kevin Peikert; Andreas Hermann; Adrian Danek
Journal:  Transfus Med Hemother       Date:  2022-01-25       Impact factor: 3.747

2.  Enlarging the clinical spectrum of chorea-acanthocytosis.

Authors:  Ilaria Sammarra; Alessia Giugno; Marco Rossi; Franco Pucci; Angelo Labate
Journal:  Neurol Sci       Date:  2021-11-22       Impact factor: 3.307

Review 3.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

Review 4.  Movement Disorders and Hematologic Diseases.

Authors:  Roshni Abee Patel; Deborah A Hall; Sheila Eichenseer; Meagan Bailey
Journal:  Mov Disord Clin Pract       Date:  2020-12-29

5.  The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.

Authors:  Bradleigh D Hayhow; Islam Hassan; Jeffrey C L Looi; Francesco Gaillard; Dennis Velakoulis; Mark Walterfang
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-08-26

6.  Facial cellulitis revealing choreo-acanthocytosis: a case report.

Authors:  Younes Samia; Cherif Yosra; Bellazreg Foued; Aissi Mouna; Berriche Olfa; Souissi Jihed; Braham Hammadi; Frih-Ayed Mahbouba; Letaief Amel; Sfar Mohamed Habib
Journal:  Pan Afr Med J       Date:  2014-04-28

7.  Identification of rare causal variants in sequence-based studies: methods and applications to VPS13B, a gene involved in Cohen syndrome and autism.

Authors:  Iuliana Ionita-Laza; Marinela Capanu; Silvia De Rubeis; Kenneth McCallum; Joseph D Buxbaum
Journal:  PLoS Genet       Date:  2014-12-11       Impact factor: 5.917

8.  Chorea-acanthocytosis: Homozygous 1-kb deletion in VPS13A detected by whole-genome sequencing.

Authors:  Susan Walker; Rubina Dad; Bhooma Thiruvahindrapuram; Muhammed Ikram Ullah; Arsalan Ahmad; Muhammad Jawad Hassan; Stephen W Scherer; Berge A Minassian
Journal:  Neurol Genet       Date:  2018-05-18

9.  OCD symptoms in succinic semialdehyde dehydrogenase (SSADH) deficiency: a case report.

Authors:  Sachin Phakey; Thomas Rego; Frank Gaillard; Julie Panetta; Andrew Evans; Gerard De Jong; Mark Walterfang
Journal:  BMC Psychiatry       Date:  2020-08-05       Impact factor: 3.630

10.  Chorea-Acanthocytosis Presenting as Autosomal Recessive Epilepsy in a Family With a Novel VPS13A Mutation.

Authors:  Juliane Weber; Lars Frings; Michel Rijntjes; Horst Urbach; Judith Fischer; Cornelius Weiller; Philipp T Meyer; Stephan Klebe
Journal:  Front Neurol       Date:  2019-01-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.